Severity of acute and chronic urticaria correlates with D-dimer level, but not C-reactive protein or total IgE
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Baek, Y. S. | - |
dc.contributor.author | Jeon, J. | - |
dc.contributor.author | Kim, J. H. | - |
dc.contributor.author | Oh, C. H. | - |
dc.date.accessioned | 2021-09-05T04:23:03Z | - |
dc.date.available | 2021-09-05T04:23:03Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-10 | - |
dc.identifier.issn | 0307-6938 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/97158 | - |
dc.description.abstract | BackgroundAlthough various scoring systems for measuring urticaria severity have been introduced, most rely on subjective criteria. Therefore, additional objective criteria such as laboratory markers would be helpful adjuncts in making this assessment. AimTo evaluate the usefulness of three laboratory markers [D-dimer, C-reactive protein (CRP), and total IgE] in assessing disease severity of both acute urticaria (AU) and chronic urticaria (CU). MethodsWe conducted a retrospective analysis of 94 patients with urticaria. Correlations between the aforementioned laboratory markers and the Urticaria Activity Score (UAS) were calculated. ResultsA substantial proportion of patients with urticaria (acute 43.5%; chronic 39.6%) had an increased D-dimer level. Additionally, there was a significant correlation between D-dimer level and UAS (AU r=0.60, P<0.001; CU r=0.37, P<0.05). However, there was no significant correlation between UAS and either CRP or total IgE. ConclusionsD-dimer level could be used as a marker of disease severity for both AU and CU. However, CRP and total IgE are not as reliable in predicting disease severity. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.subject | RESISTANT CHRONIC URTICARIA | - |
dc.subject | PLASMA-LEVELS | - |
dc.subject | DISEASE-ACTIVITY | - |
dc.subject | BLOOD-COAGULATION | - |
dc.subject | SERUM | - |
dc.subject | MATRIX-METALLOPROTEINASE-9 | - |
dc.subject | ACTIVATION | - |
dc.subject | HISTAMINE | - |
dc.subject | NEOPTERIN | - |
dc.title | Severity of acute and chronic urticaria correlates with D-dimer level, but not C-reactive protein or total IgE | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Baek, Y. S. | - |
dc.contributor.affiliatedAuthor | Jeon, J. | - |
dc.contributor.affiliatedAuthor | Oh, C. H. | - |
dc.identifier.doi | 10.1111/ced.12413 | - |
dc.identifier.scopusid | 2-s2.0-84927521890 | - |
dc.identifier.wosid | 000342162800004 | - |
dc.identifier.bibliographicCitation | CLINICAL AND EXPERIMENTAL DERMATOLOGY, v.39, no.7, pp.795 - 800 | - |
dc.relation.isPartOf | CLINICAL AND EXPERIMENTAL DERMATOLOGY | - |
dc.citation.title | CLINICAL AND EXPERIMENTAL DERMATOLOGY | - |
dc.citation.volume | 39 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 795 | - |
dc.citation.endPage | 800 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Dermatology | - |
dc.relation.journalWebOfScienceCategory | Dermatology | - |
dc.subject.keywordPlus | RESISTANT CHRONIC URTICARIA | - |
dc.subject.keywordPlus | PLASMA-LEVELS | - |
dc.subject.keywordPlus | DISEASE-ACTIVITY | - |
dc.subject.keywordPlus | BLOOD-COAGULATION | - |
dc.subject.keywordPlus | SERUM | - |
dc.subject.keywordPlus | MATRIX-METALLOPROTEINASE-9 | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | HISTAMINE | - |
dc.subject.keywordPlus | NEOPTERIN | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.